GNH USA

Europe — EMA

Lipocat

GNH USA supplies Lipocat (Atorvastatin/Ezetimibe), a lipid‑lowering combination for hypercholesterolemia and mixed dyslipidemia. Request a quote today.

Atorvastatin, Ezetimibe

Request sourcing

1
Pack/s

What is Atorvastatin, Ezetimibe?

Atorvastatin, the active ingredient in Lipocat, is a statin and cholesterol absorption inhibitor presented as an oral tablet for oral use. It treats hypercholesterolemia and mixed dyslipidemia in adult patients.

GNH USA supplies Lipocat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Atorvastatin, Ezetimibe used for?

Lipocat combines a statin with a cholesterol absorption inhibitor to manage elevated lipid levels.

Hypercholesterolemia: lowers LDL‑cholesterol and total cholesterol levels. Mixed dyslipidemia: improves the overall lipid profile by reducing LDL and triglycerides while modestly raising HDL. Primary hyperlipidemia: provides a dual mechanism to achieve greater reductions in total cholesterol and triglycerides than either component alone.

What are the side effects of Atorvastatin, Ezetimibe?

Adverse reactions reported with the atorvastatin/ezetimibe combination are grouped by frequency.

Common Side Effects: - Muscle aches or weakness - Elevated liver enzymes - Diarrhea or abdominal discomfort - Headache

Serious or Rare Side Effects: - Rhabdomyolysis (muscle breakdown) - Severe liver injury (hepatitis, jaundice) - Allergic reactions (rash, swelling, anaphylaxis)

What precautions apply to Atorvastatin, Ezetimibe?

When prescribing Lipocat, clinicians should observe the following precautions.

Liver function monitoring: assess baseline transaminases and repeat periodically. Muscle symptom vigilance: educate patients to report unexplained muscle pain or weakness. Pregnancy avoidance: contraindicated in pregnancy (Category X). Breastfeeding caution: not recommended for nursing mothers. Drug interaction awareness: review concomitant CYP3A4 inhibitors and fibrates. Store at ambient temperature: keep in the original container, protect from moisture.

What does Atorvastatin, Ezetimibe interact with?

Lipocat may interact with other medicines; interactions are classified by clinical significance.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole) - Gemfibrozil (increases risk of myopathy) - Cyclosporine (elevates statin plasma levels)

Moderate Interactions (Monitor Closely): - Antacids (may reduce ezetimibe absorption) - Warfarin (potential INR alterations) - Digoxin (possible concentration changes)

Frequently asked questions

What is Lipocat used for?+
Lipocat is prescribed to lower elevated cholesterol and triglyceride levels in adults with hypercholesterolemia, mixed dyslipidemia, or primary hyperlipidemia. It combines a statin and a cholesterol absorption inhibitor to achieve greater reductions in LDL‑C and total cholesterol than either agent alone.
How does the active ingredient work?+
Atorvastatin blocks HMG‑CoA reductase, reducing the liver’s production of cholesterol and increasing LDL‑receptor activity. Ezetimibe inhibits the NPC1L1 transporter in the intestine, decreasing the absorption of dietary and biliary cholesterol. Together they lower circulating cholesterol through complementary mechanisms.
What is the usual dose of Lipocat?+
The specific dose of Lipocat is determined by the prescribing clinician based on the patient’s lipid profile, cardiovascular risk, and tolerance. Dosage adjustments are made according to clinical response and laboratory monitoring, following local prescribing guidelines.
Is Lipocat safe during pregnancy or breastfeeding?+
Lipocat is classified as pregnancy category X, meaning it is contraindicated in pregnancy because of potential fetal harm. It is also not recommended for breastfeeding mothers, as the drug may be excreted in breast milk and could affect the infant.
How do I order Lipocat from GNH USA?+
To order Lipocat, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Lipocat compare with other lipid‑lowering drugs?+
Compared with a statin alone, Lipocat offers additional LDL‑C reduction because ezetimibe blocks intestinal cholesterol absorption. This dual approach can achieve up to 20 % greater LDL‑C lowering than high‑intensity statin therapy alone, making it useful when target lipid levels are not reached with a single agent.
What are the storage requirements for Lipocat?+
Lipocat tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Do not store in areas with high humidity or extreme heat, and keep out of reach of children.
How is Lipocat administered?+
Lipocat is taken orally, usually once daily, with or without food, as directed by the prescribing healthcare professional. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.
What are the most serious risks associated with Lipocat?+
The most serious risks include rhabdomyolysis, a severe form of muscle breakdown that can lead to kidney failure, and significant liver injury manifested by marked elevations in transaminases or hepatitis. Patients should report unexplained muscle pain, weakness, dark urine, or jaundice promptly.
Who should not use Lipocat?+
Lipocat should not be used by individuals with active liver disease, unexplained persistent elevations of hepatic enzymes, known hypersensitivity to atorvastatin, ezetimibe, or any excipients, and it is contraindicated in pregnant or nursing women. Caution is also advised in patients taking strong CYP3A4 inhibitors.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Atorvastatin, Ezetimibe
Route
Oral Use
Manufacturer
Elpen Pharmaceutical Co. Inc.
Origin
EU

Related products